SDS

Report No.: CMC220124003M01
101, Building B, Kaihuimao Industrial Park, Liyuan Road, Heping Community, Fuhai Street, Baoan District, Shenzhen, Guangdong, China
400-1668-320
[e-mail]
www.cmczj-lab.com
10 / 18
Component Information
Chemical Name
Oral LD50
Dermal LD50
Inhalation LC50
Manganese dioxide
1313-13-9
-
-
-
Iron
7439-89-6
-
-
-
Graphite
7782-42-5
-
-
-
Potassium hydroxide
1310-58-3
-
-
-
Zinc
7440-66-6
-
-
-
Zinc oxide
1314-13-2
-
-
-
Indium hydroxide
20661-21-6
-
-
-
Poly[imino-1,6-hexanediyli
mino(1,9-dioxo-1,9-nonan
ediyl)]
28757-63-3
--
-
-
Copper
7440-50-8
-
-
(b) Information on toxicological effects
Symptoms
Erythema (skin redness). May cause redness and tearing of the eyes. May cause
blindness. Burning. Itching. Rashes. Hives. Symptoms of allergic reaction may
include rash, itching, swelling, trouble breathing, tingling of the hands and feet,
dizziness, lightheadedness, chest pain, muscle pain, or flushing. Coughing and/ or
wheezing.
(c) Delayed and immediate effects as well as chronic effects from short and long-term exposure
Sensitization:
May cause sensitization of susceptible persons. May cause sensitization by skin
contact. May cause sensitization by inhalation.
Mutagenic Effects:
There is no data available for this product. Contains a known or suspected
mutagen.
Carcinogenicity:
The table below indicates whether each agency has listed any ingredient as a
carcinogen.
Chemical Name
ACGIH
IARC
NTP
OSHA
Manganese dioxide
1313-13-9
A1
Group 2B
Known
X
Iron
A1
Group 1
Known
X